News >

Study Suggests Role for Anti-PD-1/PD-L1 Agents in Advanced Thyroid Cancer

Lisa Astor
Published: Thursday, Aug 29, 2019

Results of a retrospective Chinese study suggest that among patients with medullary thyroid cancer (MTC), PD-L1 positive status is linked to more aggressive clinicopathological features and predictive of structural and biochemical recurrences.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting ReviewAug 30, 20201.5
Publication Bottom Border
Border Publication